Navigation Links
UCSD scientists receive prestigious Hartwell Biomedical Research Awards
Date:4/6/2011

Three scientists at the University of California, San Diego School of Medicine are among this year's 12 winners of Hartwell Individual Biomedical Research Awards, honoring researchers whose work advances children's health.

The UC San Diego recipients are Jack Bui, MD, PhD, assistant professor in the Department of Pathology; Pamela Itkin-Ansari, PhD, assistant professor in the Department of Pediatrics; and Adriana Tremoulet, MD, assistant adjunct professor in the Department of Pediatrics. Each will receive a $100,000 grant annually from the Hartwell Foundation for three years to cover direct research costs.

It is only the second time in the history of the Hartwell awards that a single institution has had three winners in the same year. The Hartwell Foundation also ranks UC San Diego among the top ten centers for biomedical research in the country.

"This year, UC San Diego made an extraordinary effort to nominate a terrific group of researchers for the Hartwell Individual Biomedical Research Award," said Frederick Dombrose, PhD, president of The Hartwell Foundation. "We applaud their diligence in identifying such innovative science with the potential to benefit children."

While Bui, Itkin-Ansari and Tremoulet share a common goal of improving the understanding and treatment of childhood diseases, their particular pursuits are notably diverse. Bui is interested in helping the body's immune system better recognize and kill tumor cells. Itkin-Ansari is looking for ways to improve treatment of Type-1 diabetes. And Tremoulet is focusing on finding biomarkers for Kawasaki disease, a mysterious vascular disorder of unknown cause.

"The Hartwell Foundation has a rigorous evaluation process to select individuals with novel, early stage research projects that are high risk but have a high potential reward for improving children's health," said Gordon Gill, MD, dean for scientific affairs at the School of Medicine. "We are proud that Drs. Bui, Itkin-Ansari and Tremoulet have received this recognition and much-needed support to move their research to a new level."

Jack Bui

In the United States, cancer is the leading cause of disease-related death in children under the age of 20. Each year, thousands of children are diagnosed with cancer. Despite massive investments of time and resources, the need for new, innovative cancer therapeutics for this population remains acute.

In a paradigm shift, Bui suggests a solution may lie within. The idea is based on spontaneous remission from terminal cancer, cases in which it's believed the body's own immune system attacked and destroy cancerous cells. Although such documented remissions are quite rare, it's believed the phenomenon happens more frequently, typically in individuals whose cancer is cured before they are even diagnosed.

Bui proposes to understand how spontaneous remission of terminal cancer can be duplicated; how the body's innate immune system recognizes developing tumor cells, then isolates and destroys them. His working hypothesis is that certain genes expressed in cancer cell lines can be used to therapeutically to stimulate the immune system to eradicate cancers like sarcoma.

Pamela Itkin-Ansari

Type-1 diabetes is a disease in which normal pancreatic cells are destroyed by the patient's own immune system causing the loss of insulin production, a hormone essential to regulating carbohydrate and fat metabolism in the body. Children are notably impacted: Of the estimated 850,000 to 1.7 million Americans who have Type 1 diabetes, 125,000 are 19 years and younger. An additional 30,000 Americans develop Type 1 diabetes each year, roughly 13,000 are children.

With collaborators at the Sanford/Burnham Institute for Medical Research, Itkin-Ansari has shown in a mouse model that transplanted pancreatic beta cells can be shielded from the immune system when encapsulated in a synthetic device. In theory, such a device could provide essential protection to transplanted pancreatic beta-cells in overcoming the autoimmune response that characterizes Type 1 diabetes. If successful, her encapsulated cell technique will not require tissue matching and will not have a requirement for immunosuppression, thus transforming the health and quality of life for diabetic children

Adriana Tremoulet

Kawasaki disease is a rare condition in children that involves inflammation of blood vessels. It is the leading cause of pediatric acquired heart disease in the United States, yet there is no diagnostic test for KD. Current diagnoses are limited to overt clinical signs, such as rash and fever, but these symptoms overlap with other infections and conditions, many of which require no treatment. In up to a third of KD cases, many of the clinical signs are not even present.

Finding single, tell-tale biomarkers for KD has been problematic. Tremoulet proposes to identify a novel panel of biomarkers that will differentiate KD patients from children with benign rash-fever illnesses. If successful, she expects a point of service test for diagnosing KD will be available in every emergency room, pediatric office, and urgent care center in the U.S. within 5-10 years.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Fox Chase scientists report interplay between cancer and aging in mice
2. U-M scientists find potential driver of some aggressive prostate cancers
3. Scientists Spot 4 New Alzheimers Genes
4. Scientists identify KRAS rearrangements in metastatic prostate cancer
5. Smithsonian scientists find declining rainfall is a major influence for migrating birds
6. Scientists devise targeted therapy strategy for rare form of childhood cancer
7. Scientists Create Autism-Like Traits in Mice
8. Scientists find candidate for new TB vaccine
9. Scientists find a key to maintaining our DNA
10. Scientists ID possible biomarker to gauge Alzheimers prognosis, effect of therapies
11. Scientists identify molecule that can increase blood flow in vascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: